Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s share price dropped 2.2% during trading on Tuesday . The stock traded as low as $2.25 and last traded at $2.25. Approximately 750 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 2,814 shares. The stock had previously closed at $2.30.
Idorsia Price Performance
The company’s 50 day simple moving average is $2.39 and its 200 day simple moving average is $2.16.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Featured Stories
- Five stocks we like better than Idorsia
- Investing in Travel Stocks Benefits
- Sales Breakout Sends This Semiconductor Stock to Record High
- What Are Dividend Achievers? An Introduction
- Surprise Buying Opportunity on This Dividend Aristocrat
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
